Walleye Capital
KRRO icon

Walleye Capital’s Korro Bio KRRO Stock Holding History

Walleye Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,060
Closed -$201K – 4828
2025
Q2 		$201K Sell
16,060
-14,895
-48% -$214K ﹤0.01% 3366
2025
Q1 		$539K Sell
30,955
-10,273
-25% -$305K ﹤0.01% 2499
2024
Q4 		$1.57M Buy
+41,228
New +$2.12M ﹤0.01% 2002
2024
Q3 		– Sell
-29,534
Closed -$1M – 5597
2024
Q2 		$1M Buy
+29,534
New +$1.63M ﹤0.01% 2850
2022
Q2 		– Sell
-1,583
Closed -$168K – 2549
2022
Q1 		$168K Sell
1,583
-1,341
-46% -$256K ﹤0.01% 1589
2021
Q4 		$750K Buy
2,924
+523
+22% +$159K 0.02% 746
2021
Q3 		$847 Buy
2,401
+1,057
+79% +$416K 0.02% 544
2021
Q2 		$669 Sell
1,344
-12
-0.9% -$5.86K 0.02% 635
2021
Q1 		$644 Buy
+1,356
New +$2.63M 0.04% 470

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital's KRRO Position: Q3 2025 in Review

Walleye Capital sold out of Korro Bio (KRRO) in Q3 2025, closing a stake of 16,060 shares — an estimated $201K sold.

Walleye Capital first reported a position in KRRO in Q1 2021 and held it in 9 quarters. The position peaked at $1.57M in Q4 2024. 92 funds tracked by Wall St. Rank hold KRRO as of Q3 2025.

  • Walleye Capital reported no remaining Korro Bio position as of Q3 2025 after selling out during the quarter.
  • Walleye Capital sold 16,060 Korro Bio shares in Q3 2025, an estimated $201K.
  • Walleye Capital first reported a position in Korro Bio in Q1 2021 and held it in 9 quarters.
  • Walleye Capital's Korro Bio position peaked at $1.57M in Q4 2024.
  • 92 funds tracked by Wall St. Rank held Korro Bio as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.